Cocaine tolerance: Behavioral, cardiovascular, and neuroendocrine function in men

Neuropsychopharmacology

Volumn 18, Issue 4, 1998, Pages 263-271

  Mendelson, Jack H ^a   Sholar, Michelle ^a   Mello, Nancy K ^a   Teoh, Siew Koon ^a   Sholar, J Wallis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ACTH; Blood pressure; Cocaine; Euphoria; Pharmacokinetics; Tachycardia

Indexed keywords

COCAINE; CORTICOTROPIN;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG TOLERANCE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; BEHAVIOR; BLOOD PRESSURE; COCAINE; DRUG TOLERANCE; HEMODYNAMIC PROCESSES; HUMANS; MALE; NARCOTICS; NEUROSECRETORY SYSTEMS; RADIOIMMUNOASSAY; SUBSTANCE-RELATED DISORDERS;

EID: 0031883321     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00146-2     Document Type: Article

References (60)

1. Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin S, Atkinson AJ Acute tolerance to cocaine in humans. Clin Pharmacol Ther. 44:1988;1-8.
2. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. DSM-IV. Washington, DC, American Psychiatric Association.
3. Bilsky EJ, Montegut MJ, Delong CL, Reid LD Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;PL85-PL90.
4. Borowsky B, Kuhn CM Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543:1991;301-306.
5. Borowsky B, Kuhn CM Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther. 256:1991;204-210.
6. Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 505:1989;7-11.
7. Castellani S, Ellinwood E, Kilbey M Behavioral analysis of chronic cocaine intoxication in the cat. Biol Psychiatry. 13:1978;203-215.
8. Chow MJ, Ambre JJ, Ruo TI, Atkinson AJ, Bowsher DJ, Fischman MW Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharm Ther. 38:1985;318-324.
9. Condelli WS, Fairbank JA, Dennis ML, Rachal JV Cocaine use by clients in methadone programs. Significance, scope, and behavioral interventions J Subst Abuse Treat. 8:1991;203-212.
10. Cunningham KA, Paris JM, Goeders NE Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci. 654:1992;117-127.
11. Cunningham ST, Finn M, Kelley AE Sensitization of the locomotor response to psychostimulants after repeated opiate exposure. Role of the nucleus accumbens Neuropsychopharmacology. 16:1997;147-155.
12. Cunningham ST, Kelley AE Evidence for opiate-dopamine cross-sensitization in nucleus accumbens. Studies of conditioned reward Brain Res Bull. 29:1992;675-680.
13. DuMars LA, Rodger LD, Kalivas PW Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res. 27:1988;87-91.
14. Dunn AJ, Berridge CW Physiological and behavioral responses to corticotropin-releasing factor administration. Is CRF a mediator of anxiety or stress responses Brain Res Rev. 15:1990;71-100.
15. Ellenhorn MJ, Barceloux DG Medical Toxicology. 1988;Elsevier, New York. pp 643-641.
16. Fischman MW, Schuster CR, Hatano Y A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans. Pharmacol Biochem Behav. 18:1983;123-127.
17. Fischman MW, Schuster CR, Javaid JK, Hatono Y, Davis J Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther. 235:1985;677-682.
18. Foltin RW, Christiansen I, Levin FR, Fischman MW Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther. 275:1995;38-47.
19. Foltin RW, Fischman MW Smoked and intravenous cocaine in humans. Acute tolerance, cardiovascular and subjective effects J Pharmacol Exp Ther. 257:1991;247-261.
20. Foltin RW, Fischman MW Self-administration of cocaine by humans. Choice between smoked and intravenous cocaine J Pharmacol Exp Ther. 231:1992;841-849.
21. Gastfriend DR, Mendelson JH, Mello NK, Teoh SK, Reif S Buprenorphine pharmacotherapy for concurrent heroin and cocaine dependence. Am J Addict. 2:1993;269-278.
22. Goeders NE, Guerin GF Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res. 722:1996;145-152.
23. Howell SL, Ezell AL An example of cocaine tolerance in a gunshot wound fatality. J Anal Toxicol. 14:1990;6-7.
24. Jacob P, Elias-Baker GA, Jones RT, Benowitz NL Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. J Chromatogr. 417:1987;277-286.
25. Jaffe J Drug addiction and drug abuse. Goodman AG, Goodman LS, Rall TW, Murad F The Pharmacological Basis of Therapeutics. 1985;535-584 Macmillan, New York.
26. Kalivas PW Interactions between neuropeptides and dopamineneurons in the ventromedial mesencephalon. Neurosci Biobehav Rev. 9:1985;573-587.
27. Kalivas PW, Striplin CD, Steketee JD, Klitenick MA, Duffy P Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann NY Acad Sci. 654:1992;128-135.
28. 2 receptor function. J Pharmacol Exp Ther. 269:1994;743-749.
29. Kosten TR, Kleber HD, Morgan C Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 44:1989;887-892.
30. Kosten TR, Rounsaville BJ, Gawin FH, Kleber HD A 2.5-year follow-up of cocaine use among treated opioid addicts. Arch Gen Psychiatry. 44:1987;281-284.
31. Kumor KM, Sherer MA, Cascella NG Cocaine use in man. Subjective effects, physiologic responses, and toxicity Redda KK, Walker CA, Barnett G Cocaine, Marijuana, Designer Drugs. Chemistry, Pharmacology and Behavior:1989;83-96 CRC Press, Inc, Boca Raton, FL.
32. Levy AD, Li Q, Alvarez Sanz MC, Rittenhouse PA, Kerr JE, Van de Kar LD Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci. 51:1992;887-897.
33. Levy AD, Li Q, Kerr JE, Rittenhouse PA, Milonas G, Cabrera TM, Battaglia G, Alvarez Sanz MC, Van de Kar LD Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J Pharmacol Exp Ther. 259:1991;495-500.
34. Marinelli M, Route-Pont F, DeJesus-Oliveira C, LeMoal M, Piazza PV Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology. 16:1997;156-161.
35. Mello NK, Mendelson JH Buprenorphine's effects on cocaine and heroin abuse. Korenman S, Barcus J The Biological Basis of Substance Abuse. 1993;463-485 Oxford University Press, New York.
36. Mello NK, Mendelson JH Buprenorphine treatment of cocaine and heroin abuse. Cowan A, Lewis JW Buprenorphine. Combatting Drug Abuse with a Unique Opioid:1995;241-287 Wiley-Liss, Inc, New York.
37. Mello NK, Mendelson JH, Bree MP, Lukas S Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther. 254:1990;926-939.
38. Mello NK, Mendelson JH, Bree MP, Lukas SE Buprenorphine suppresses cocaine self-administration by rhesus monkey. Science. 245:1989;859-862.
39. Mendelson JH, Teoh SK, Mello NK, Ellingboe J Buprenorphine attenuates the effects of cocaine on adrenocorticotrophin (ACTH) secretion and mood states in man. Neuropsychopharmacology. 17:1992;157-162.
40. Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E Acute effects of cocaine on plasma adrenocorticotropic hormones, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther. 263:1992;505-509.
41. Moldow RL, Fischman AJ Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides. 8:1987;819-822.
42. Negus SS, Gatch MB, Mello NK (1997): Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology (in press).
43. O'Brien CP Drug addiction and drug abuse. Goodman G, Gilman G The Pharmacological Basis of Therapeutics. 9:1996;557-559 McGraw-Hill, New York.
44. Post RM, Weiss SR Psychomotor stimulant vs. local anesthetic effects of cocaine. Role of behavioral sensitization and kindling. NIDA Res Monogr 88:1988;217-238.
45. Post RM, Weiss SR, Pert A Implications of behavioral sensitization and kindling for stress-induced behavioral change. Adv Exp Med Biol. 245:1988;441-463.
46. Preston KL, Sullivan JT, Strain EC, Bigelow GE Enhancement of cocaine's abuse liability in methadone maintained patients. Psychopharmacology. 123:1996;15-25.
47. Rivier C, Vale W Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
48. Sarnyai Z, Biro E, Penke B, Telegdy G The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res. 589:1992;154-156.
49. Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR Buprenorphine. Dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans Biol Psychiatry. 34:1993;66-74.
50. Spealman RD, Bergman J Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther. 261:1992;607-615.
51. Spealman RD, Bergman J Opioid modulation of the discriminative stimulus effects of cocaine. Comparison of μ, κ, and δ agonists in squirrel monkeys discriminating low doses of cocaine Behav Pharmacol. 5:1994;21-31.
52. Stripling JS, Ellinwood EH Jr. Sensitization to cocaine following chronic administration in the rat. Ellinwood EH Jr., Kilbey MD Cocaine and Other Stimulants. 1977;327-351 Plenum Press, New York.
53. Tallarida RJ, Murray RB Manual of Pharmacologic Calculations with Computer Programs. 2:1991;Springer-Verlag, New York.
54. Teoh SK, Mendelson JH, Mello NK, Kuehnle J, Sintavanarong P, Rhoades EM Acute interactions of buprenorphine with intravenous cocaine and morphine. An investigational new drug phase I safety evaluation J Clin Psychopharmacol. 13:1993;87-99.
55. Teoh SK, Sarnyai Z, Mendelson JH, Mello NK, Springer SA, Sholar JW, Wapler M, Gelles H Cocaine effects on pulsatile secretion of ACTH in men. J Pharmacol Exp Ther. 270:1994;1134-1138.
56. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ 0. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration J Pharmacol Exp Ther. 270:1994;1387-1396.
57. Vescovi PP, Coivo V, Volpi R, Passeri M Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts. Horm Res. 37:1992;221-224.
58. Vezina P, Giovino AA, Wise RA, Stewart J Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav. 32:1989;581-584.
59. Vezina P, Stewart J Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine. Lack of conditioned effects Brain Res. 516:1990;99-106.
60. Zahniser NR, Peris J, Dwoskin LP, Curella P, Uasuda RP, O'Keefe L, Boyson SJ Sensitization to cocaine in the nigrostriatal dopamine system. NIDA Res Monogr. 88:1988;55-77.